UK markets close in 6 hours 32 minutes
  • FTSE 100

    6,678.31
    -37.11 (-0.55%)
     
  • FTSE 250

    20,644.07
    -149.65 (-0.72%)
     
  • AIM

    1,192.96
    -5.13 (-0.43%)
     
  • GBP/EUR

    1.1225
    -0.0056 (-0.50%)
     
  • GBP/USD

    1.3666
    -0.0064 (-0.47%)
     
  • BTC-GBP

    23,214.26
    +1,009.72 (+4.55%)
     
  • CMC Crypto 200

    626.83
    +16.84 (+2.76%)
     
  • S&P 500

    3,853.07
    +1.22 (+0.03%)
     
  • DOW

    31,176.01
    -12.37 (-0.04%)
     
  • CRUDE OIL

    52.19
    -0.94 (-1.77%)
     
  • GOLD FUTURES

    1,859.30
    -6.60 (-0.35%)
     
  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     
  • HANG SENG

    29,447.85
    -479.91 (-1.60%)
     
  • DAX

    13,785.38
    -121.29 (-0.87%)
     
  • CAC 40

    5,528.06
    -62.73 (-1.12%)
     

Global Ibuprofen Market (by Product, Dosage Form, Process & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

ReportLinker
·2-min read

The global ibuprofen market is projected to reach US$7. 54 billion in 2024, progressing at a CAGR of 2. 47%, over the period 2020-2024. The factors such as upsurge in healthcare expenditure, rising prevalence of arthritis, surging incidence of cancer cases, expanding urbanization and escalating sales of analgesic drugs would drive the growth of the market.

New York, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Ibuprofen Market (by Product, Dosage Form, Process & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" - https://www.reportlinker.com/p06003549/?utm_source=GNW
However, the market growth would be challenged by adverse side effects and increase in the price of raw materials. A few notable trends include mounting e-commerce penetration, upswing in sports injuries, surging occurrence of chronic disorders and increasing public awareness.

The global ibuprofen market has been categorized on the basis of product, dosage form and process. On the basis of product, the global ibuprofen market can be bifurcated into United States Pharmacopoeia (USP) and European Pharmacopoeia (EP). According to the dosage form, the global ibuprofen market can be split into tablets, suspension & solution and other forms such as capsules, gels and creams. Whereas, the ibuprofen market can be segmented into oral and intravenous, on the basis of process.

The fastest growing regional market is North America due to improvements in healthcare infrastructure coupled with growing demand for ibuprofen due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation and gastrointestinal events, growing research and development activities for the development of innovative drugs and rising prevalence of chronic diseases such as respiratory disorders, heart disease, obesity, and asthma in the region.

Scope of the report:

• The report provides a comprehensive analysis of the global ibuprofen market segmented on the basis of product type, dosage form, process and region.
• The major regional and country markets (North America, Europe, Asia Pacific (APAC) and Latin America, Middle East & Africa (LAMEA) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (BASF SE, Perrigo Company PLC, Shandong Xinhua Pharmaceutical Co., Ltd., Strides Pharma Science Limited, IOL Chemicals & Pharmaceuticals Ltd. and SI Group, Inc.) are also presented in detail.

Key Target Audience:

• Ibuprofen Manufacturers
• Ibuprofen Distributors/Traders/Wholesalers
• Pharmaceutical Companies
• Downstream Vendors
• Government Bodies & Regulating Authorities
Read the full report: https://www.reportlinker.com/p06003549/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001